Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
92
NCT00527319
Regimen for the Treatment of Cachexia in Subjects With NSCLC
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2007
Completion: Sep 30, 2008
NCT01265576
Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)
Start: Dec 31, 2010
Completion: Apr 30, 2016
NCT01857817
Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer
Start: Jun 30, 2013